PECO Phillips Q1 2026 earnings vastly outperform analyst forecasts shares rise modestly after results NRXP NRX Pharmaceuticals shares climb 352 percent as investors shrug off worse than expected Q4 2025 EPS miss WLACU Willow shares new details on its SPAC merger target pipeline in latest quarterly report